Several months ago, the weight loss drug Hydrocut was recalled due to links to liver damage. The FDA is now investigating another weight loss drug-Alli, made and sold by GlaxoSmithKline. In 2007, Alli was approved as the only non-prescription weight loss drug. The FDA is reconsidering that approval. In June, the FDA noted on its website that Orlistat, a form of Alli, is potentially harmful. There have been adverse event reports fir Alli which highlight possible liver problems, including hepatoxicology, … Continue Reading >